[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-detail-362295-en":59,"doc-seo-362295-105":98},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":5,"data":60},{"doc_id":61,"user_id":62,"nickname":63,"user_avatar":64,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":66,"doc_content":67,"file_id":68,"file_url":69,"file_type":70,"file_size":71,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":72,"language_code":73,"site_id":74,"html_lang":73,"table_of_contents":75,"faqs":76,"seo_title":77,"seo_description":66,"update_tm":78,"read_time":79,"preview_page_count":19,"preview_urls":80},362295,1099514068365,"Aurelia","https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","Factors determining survival in oligometastatic breast cancer - A retrospective cohort study from a low and middle income country","Metastatic breast cancer shows poor prognosis, whereas oligometastatic breast cancer demonstrates heterogeneous outcomes. This retrospective cohort analysis evaluated factors influencing 5-year survival among patients undergoing upfront resection, using a 10-year chart review from a tertiary referral hospital with follow-up of at least 5 years post-surgery. Overall and progression-free survival were estimated from surgery dates via Cox proportional hazards, while logistic regression assessed pre- and post-operative associated factors. Patients were selected from low- and middle-income country care pathways to quantify prognostic markers and survival patterns.","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nFactors determining survival inoligometastatic breast cancer in a retrospective cohort study from a low and middle income country  \nKulsoom Shaikh1, Muhammad Uzair2, Lubna Mushtaq Vohra1􀀍 & SakinaAbidi3  \nMetastatic breast cancer has historically had a poor prognosis, but oligometastatic breast cancer shows differing outcomes. We analyzed the factors affecting 5-year survival for patients undergoing upfront resection. We conducted a 10-year chart review from a tertiary referral hospital. Patients were followed for at least 5 years after surgery. Overall and progression free survival were calculated from date of surgery using cox-proportional hazards while logistic regression was used to evaluate the pre-and post-operative factors associated with surgery. 55 patients with a mean age of 50.4 years were included. Most patients had T4, N1/N2 stage disease on presentation. The most common site of metastasis was lungs. The median overall survival was 111 months with a 5-year survival rate  \nof 64.6%(47.9%, 77.2%). There were 18 distant and 1 local recurrence and 20 deaths in our cohort leading to a median progression free survival of 36 months. N2 nodal disease, and liver metastasis were identified as poor prognostic markers while hormone receptors increased survival (p \u003C 0.05), while locally advanced disease and triple positive tumor biology increased the risk of progression and death (p \u003C 0.05) . Patients with limited metastatic disease should be considered for upfront resection with the intent to cure, especially when triple positive tumor biology is present.  \nKeywords Breast cancer, Oligometastatic, Surgery  \nBreast cancer is the second most common cause of death in women globally. According to the Centre for Disease Control and Prevention, the incidence in the US was 7.9 per 100,000 in 20211. About 60% of breast cancerrelated mortality is reported to be concentrated in lower-and middle-income countries2. As of 2019, Pakistan was had the highest rate of breast cancer-related mortality3. Generally, a large proportion of breast cancer-related mortality can be attributed to metastatic breast cancer1. Reyes et al. estimated that almost a third of breast cancer patients succumbed to widespread metastatic disease4.  \nOligo-metastatic Breast Cancer (OMBC) is a sub-set which makes 20% of metastatic breast cancer. These are patients with limited number and sites of metastasis. Although no consensus exists on the definition of OMBS, most authors seem to agree with a version of the following definition that we used: metastatic lesions limited to one or two organs (excluding the primary resectable lesion), less than 5 lesions per organ, and diameter smaller than 5 cm per lesion5. Oligometastasis was first explained by Hellman in 1994 as restricted loco-regional tumor load with indolent behavior, for which he suggested aggressive management with chemotherapy and radiotherapy6. This concept was revisited in 2011, and it was understood that local cancer treatments are curative in a proportion of patients with metastasis, more commonly in oligometastatic cancer7. The OMBC phenotype has low metastatic potential and there is increasing evidence to advocate for aggressive local therapy for these patients in view of their increased survival and favorable prognosis.  \nOverall breast cancer survival has been improving with advances in the understanding of the biological behavior of the disease and the evolution in adjuvant treatment options8. Providing a treatment option aimed atan eventual disease-free state for OMBC patients is an exciting avenue as breast cancer treatment progresses9. Despite convincing retrospective data and ongoing prospective trials supporting radical surgery of local disease to improve survival outcomes, conflict in opinions and lack of treatment guidelines persist to treat this unique entity of patients10.  \n1Section of Breast Surgery, Department","cbCaiqDkEMXOYoOW","https://ap.wps.com/l/cbCaiqDkEMXOYoOW","pdf",1506084,"English","en",105,"# Background\n## Metastatic breast cancer and oligometastatic subset\n## Rationale for upfront surgery and treatment uncertainty\n# Aim and study overview\n## Institutional experience and intended curative approach\n# Materials and methods\n## Retrospective chart review and eligibility\n## Diagnostic workup and staging\n## Treatments included and exclusions\n# Clinical and pathological data","[{\"question\":\"What was the main objective of the study?\",\"answer\":\"To determine factors associated with overall and progression-free survival in patients with oligometastatic breast cancer who underwent upfront resection with curative intent.\"},{\"question\":\"How were survival outcomes analyzed?\",\"answer\":\"Overall and progression-free survival were calculated from the date of surgery using Cox proportional hazards, and logistic regression evaluated factors linked to survival.\"},{\"question\":\"Which patient or tumor features were linked to poorer or improved prognosis?\",\"answer\":\"N2 nodal disease and liver metastasis were identified as poor prognostic markers, while hormone receptor positivity increased survival. Locally advanced disease and triple-positive tumor biology increased the risk of progression and death.\"}]","Factors determining survival in oligometastatic breast cancer - A retrospective cohort study from a low and middle income country | PDF",1790146968,23,[81,85,89,94],{"page_no":8,"url":82,"width":83,"height":84},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cd3843fb6763f1f9179323c8a352b6c1.webp",983,1291,{"page_no":14,"url":86,"width":87,"height":88},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fc9aca759b19618f017c61e4a9e8d1bd.webp",982,1290,{"page_no":90,"url":91,"width":92,"height":93},3,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ea63015cf8bb6280e8a7ffe1cf3d35ba.webp",981,1289,{"page_no":19,"url":95,"width":96,"height":97},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3636dbece320dc29c100858efb2d9c31.webp",980,1287,{"code":4,"msg":99,"data":100},"ok",{"site_id":74,"language":73,"slug":101,"title":65,"keywords":102,"description":66,"schema_data":103,"social_meta":156,"head_meta":158,"extra_data":160,"updated_unix":161},"factors-determining-survival-in-oligometastatic-breast-cancer-a-retrospective-cohort-study-from-a-low-and-middle-income-country","",{"@graph":104,"@context":155},[105,118,138],{"@type":106,"itemListElement":107},"BreadcrumbList",[108,112,114,116],{"item":109,"name":110,"@type":111,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":113,"name":9,"@type":111,"position":14},"https://docshare.wps.com/document/",{"item":115,"name":40,"@type":111,"position":90},"https://docshare.wps.com/document/research-report/",{"item":117,"name":65,"@type":111,"position":19},"https://docshare.wps.com/document/factors-determining-survival-in-oligometastatic-breast-cancer-a-retrospective-cohort-study-from-a-low-and-middle-income-country/362295/",{"url":117,"name":65,"@type":119,"image":120,"author":125,"headline":65,"publisher":127,"fileFormat":130,"inLanguage":73,"description":66,"dateModified":131,"datePublished":132,"encodingFormat":130,"isAccessibleForFree":133,"interactionStatistic":134},"DigitalDocument",{"url":121,"@type":122,"width":123,"height":124},"https://docshare.wps.com/thumbnails/factors-determining-survival-in-oligometastatic-breast-cancer-a-retrospective-cohort-study-from-a-low-and-middle-income-country/362295.png","ImageObject",300,407,{"name":63,"@type":126},"Person",{"url":109,"name":128,"@type":129},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":135,"interactionType":136,"userInteractionCount":52},"InteractionCounter",{"@type":137},"ViewAction",{"@type":139,"mainEntity":140},"FAQPage",[141,147,151],{"name":142,"@type":143,"acceptedAnswer":144},"What was the main objective of the study?","Question",{"text":145,"@type":146},"To determine factors associated with overall and progression-free survival in patients with oligometastatic breast cancer who underwent upfront resection with curative intent.","Answer",{"name":148,"@type":143,"acceptedAnswer":149},"How were survival outcomes analyzed?",{"text":150,"@type":146},"Overall and progression-free survival were calculated from the date of surgery using Cox proportional hazards, and logistic regression evaluated factors linked to survival.",{"name":152,"@type":143,"acceptedAnswer":153},"Which patient or tumor features were linked to poorer or improved prognosis?",{"text":154,"@type":146},"N2 nodal disease and liver metastasis were identified as poor prognostic markers, while hormone receptor positivity increased survival. Locally advanced disease and triple-positive tumor biology increased the risk of progression and death.","https://schema.org",{"og:url":117,"og:type":157,"og:title":65,"og:site_name":128,"og:description":66},"article",{"robots":159,"canonical":117},"index,follow",{"doc_id":61,"site_id":74},1790193719]